Pharma Intelligence and Signals Analytics
Powering Pharma Intelligence with Advanced Analytics
20th May 2020
Join us as our industry experts explore how these technologies are used by leading pharma and biotech companies to reduce time to insight and deliver successful business outcomes in a world where every minute counts.
A Review R&D Annual Review
28th April 2020
The pharma industry is moving into a new decade, and Pharmaprojects is here with insights into what we can expect in the year ahead. Join us to examine the trends and pipelines in a new level of granular detail. Get a taste of the direction R&D is heading in the Pharma R&D Annual Review Webinar
A Decade of Biopharma M&A and Outlook for 2020
16th April 2020
Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more.
Is Biopharma Fit For the Next Decade?
1st April 2020
Industry experts will share their analysis of the current industry landscape and present their views on the future of biopharma following the impact of COVID-19 on new business opportunities and challenges.
The analyst will examine:
2020 Early Outlook Webinar
26th February 2020
Plan your strategy with an exclusive view into major clinical and regulatory milestones and large impact catalysts across a range of indications. Drawing from the intelligence across our Commercial Strategy suite (including Biomedtracker, Datamonitor Healthcare, and Pharmapremia), our analysts will examine:
Outlook for Nash Therapy and Market Dynamics
31st October 2019
Non-alcoholic steatohepatitis (NASH) is poised to become an even greater epidemic and pharma companies of all sizes are competing to be the first to bring a NASH drug to market. Listen to an in-depth discussion about new and repurposed drug exploration treat NASH, as well as deal making, licensing and partnerships activity for the area.
The Digital Health Revolution: Business Trends, Regulations and More
10th October 2019
Subject area experts from the pharma and medical devices industries take you inside the landscape for digital health. Identify trends, spot new opportunities, and plan for the risks associated with this increasingly important area in healthcare.
Manufacturing Challenges Facing Cell and Gene Therapy
19th September 2019
As more regenerative medicine products approach clinical testing and commercialization, stakeholders in the field are increasingly pressed to address substantial challenges, including pricing and reimbursement, GMP manufacturing, and clinical availability, and patient accessibility to these life changing therapies.
Q3 Outlook Webinar
15 July 2019
Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. Using their extensive experience, supported by data from Datamonitor Healthcare, Biomedtracker, and Pharmapremia, the analysts will examine:
What We Learned From Q1 Pharma Earning Season
23 May 2019
New drug launches have increased over the past couple of years, but few have reached blockbuster status yet. Meanwhile, China’s increasing appetite (and willingness to pay) for therapeutic innovation was a positive for several big pharma companies in the first quarter. Scrip’s webinar takes a deep dive into the key issues and trends emerging from industry earnings calls.
Global Market Access Trends
9 May 2019
Join subject-matter experts from Datamonitor Healthcare as they use data and their industry experience to examine the challenges and opportunities brought about by recent global trends in market access. Learn how to navigate this complex terrain, as increasingly restrictive pricing and reimbursement policies are having an adverse effect on sales of launched and pipeline products across many global markets.
Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019
Watch the Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019 webinar video recording below:
The drug R&D pipeline in 2019, and how it is changing:
Webinar: Realizing The Opportunity To Increase Quality And Improve Efficiency Of Safety Data Collection Within Patient Support Programs
21 March 2019
Patient Support Programs (PSPs) have changed dramatically over the past decade; they have become global activities, and grown significantly in scale and complexity. While PSPs are also an increasingly valuable resource for pharmacovigilance due to the extensive patient safety data they generate, they have suffered from the traditional lack of standardized mechanisms for recording, reconciling and managing this data, resulting in resource heavy processes, and a lost opportunity for deeper product understanding for Pharma. Fortunately, new technologies are helping to tackle this challenge.
Datamonitor Healthcare/ Biomedtracker
Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets
27 February 2019
Find out which market-moving events and catalysts to watch for during the upcoming Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.
During this webinar recording, industry analysts from Informa Pharma Intelligence present their data-based views on what’s in store for key drugs in early 2019. Discussion include important upcoming events related to these key drugs, their likelihood of phase/PDUFA review success and likelihood of approval, and an examination of the market significance of the drugs themselves.
The significance of key drugs mentioned in the Early 2019 Outlook Report
Webinar: What’s the Reality of Real World Evidence?
14 February 2019
The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions. More than just news, Pink Sheet delivers analysis, and commentary focused on regulatory implications, including high-value perspectives from insiders and thought leaders across the globe – giving regulatory professionals an objective view of how to anticipate challenges, minimize risks, and maximize opportunities for their business. Scrip boasts over 60 journalists and analysts dedicated to bringing you the latest news and insights with everything from licensing, clinical trials, and competitor activity. Hear directly from the newsmakers, leverage best-in-class proprietary data, and follow the latest market developments with a Scrip account.
8 November 2018
Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets
Listen to this presentation now for free, and tap into analysis of:
How Originator Companies Face Up to the Biosimilar Challenge Webinar Recording
14 November 2018
Listen to the recording now, where Scrip experts will be:
Q4 2018 Outlook Webinar
8 November 2018
Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".
Meddevicetracker, Medtech Insight
Neuromodulation Device Market - Innovations and Trends
29 October 2018
The large and growing global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide and is one of the highest growth medical device markets today and undergoing significant technological advancement by innovative start-ups and leading medical device companies. Experts from Meddevicetracker and Medtech Insights explored this exciting area in this webinar, which focused on three targeted neuromodulation segments, spinal cord stimulation (SCS), deep brain stimulation (DBS) and vagus nerve stimulation (VNS), looking at the market size, growth, and key players as well as opportunities and key challenges.
2017 Completed Clinical Trials: Status Quo or No?
24 July 2018
A completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots. Discover the state of last year's completed trials and successes, with a deep dive into the active landscapes of oncology, autoimmune/inflammation, and CNS trials and insights into sponsor drug and disease strategies.
Japan Pharma Outlook: Strategizing Growth in an Evolving Industry Landscape
20 June 2018
Japan Pharma must navigate complex pressures and opportunities presented by an aging and declining Japanese population, as well as government measures designed to encourage innovation while controlling healthcare spending, to steer a path towards long-term global revenue growth. Gain an inside view from experts on the significant growth potential of the industry, as they examine ten prominent Japanese companies and their strategies to maximize global revenue in the Japan Pharma Outlook webinar.
Pharma Intelligence with the Alliance for Regenerative Medicine
RMAT Designation: Impact on Regenerative Medicine Sector & How it Compares with Other Accelerated Approval Programs
13 June 2018
The 21st Century Cures Act, passed in December 2016, included several key regenerative medicine-specific provisions, one of which led to the creation of the Regenerative Medicine Advanced Therapies (RMAT) designation, creating an optimized, accelerated approval program specifically designed with the unique attributes of regenerative medicine products in mind. This webinar, hosted by Pharma Intelligence in partnership with the Alliance for Regenerative Medicine, explores the significance of this designation and the ongoing interest and support of the FDA to advance this critically important sector.
Medtech Insights, Meddevicetracker
Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications
6 June 2018
Robotic surgery is revolutionizing the patient experience and as technology advances, competition in the robotic surgery devices space is growing exponentially. Take a closer look at the expanding robotic surgery market during this webinar from Medtech Insight and Meddevicetracker: Robotic Surgery 4.0: Innovative Robotic Assisted Systems & Their Applications.
ASCO Essentials Webinar 2018 Recording
23 May 2018
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting
Let our experts present their top picks from the thousands of abstracts being presented at ASCO
Pharma R&D review Webinar
16 May 2018
Keep in tune with the current landscape for pharma R&D with this free, information-packed webinar recording from Informa Pharma Intelligence. In the Global Pharma R&D Review webinar, our experts hit all the right notes as they use a music theme to explore key issues affecting R&D today, and offer a glimpse of what the rest of 2018 may look like.
Companion Diagnostics Webinar
15 May 2018
Companion diagnostics are poised to be a huge growth area worldwide, with a CAGR of 20.1% over the next 5 years, making it a $6B industry by 2022. Learn more about this important, emerging area with the Companion Diagnostics Webinar recording from Informa Pharma Intelligence.
Partnership shared expertise and technology to optimize study planning webinar
24 April 2018
The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform. In collaboration with guest speakers from Bayer and ICON, our presenters share insights on how combining expertise with trusted partners, along with a few simple tech tools, can streamline the study start up journey.
HIV Market Growth webinar
19 April 2018
Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.
Dyslipidemia Market Overview
31 January 2018
Important changes are coming to the Dyslipidemia market in the coming months and years, with Datamonitor Healthcare forecasting sales from the US dyslipidemia market to rise to $22.3bn in 2025. Stay in the loop by registering for the upcoming webinar from Biomedtracker and Datamonitor Healthcare.
Biosimilars Development in Autoimmune and Inflammatory Diseases
11 October 2017
The Informa Pharma Intelligence webinar recording, "Biosimilars Development in Autoimmune and Inflammatory Diseases", is now available to watch. We hope you find the recording of the webinar helpful in gaining insight into the factors driving the biosimilars market for blockbuster drug trials helpful.
Choice Not Chance: How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial
19 September 2017
Patient recruitment into clinical trials is a challenging endeavor with 1 in 10 sites, on average, failing to enroll a single patient into a trial. Learn about strategies to help reduce the chance of selecting a non-enrolling site by viewing the webinar recording below.
2016 Clinical Trials Roundup
20 September 2017
The Clinical Trials Roundup provides an annual view of the trial landscape of the year just past, dissecting the data by therapeutic area, phase, disease, company, and more. Watch the recording of "2016 Clinical Trials Roundup: The Next Generation" to gain insight into competitive drug development strategies, presented to you by Citeline's Trialtrove, part of the Informa Pharma Intelligence family of tools.
Heart Valve Disorder and Management Markets
21 September 2017
We’d like to now invite you to download a free recording of this webinar, which offers critical insights and updates into the rapidly growing heart valve devices market.
Medtech Insight, In Vivo
The Trump Era: Challenges and Opportunities in Pharma and Medtech Policy
27 July 2017
The Trump Era: Challenges and Opportunities in Pharma and Medtech Policy, presented by senior expert analysts from Informa Pharma Intelligence. We hope you found the session to be an insightful and informative view into the implications of the first 100 days of Trump’s presidency upon the pharma and medtech industries.
View webinar recording
Oncology Success Rates
21 July 2017
Learn more about benchmarking, and the successes, or lack of success, in oncology drug development in the webinar "Oncology Success Rates", presented by: Robert Jeng, Senior Scientific Analyst, Will Akie, Product Manager for Pharmapremia, and Ellen Moore of Pharma Consulting.
2016 Completed Clinical Trials: Industry Strategies Revealed and Graded
17 July 2017
Delving into clinical trial completions provides additional insight that support comparisons of companies' strategies and performances. Using exclusive data from Citeline's Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.
Big Pharma Outlook 2026
03 July 2017
Big Pharma is poised for growth due to strong launch portfolios, the availability of high-potential pipeline assets, and companies’ sharpened focus on high-performing markets. Watch the Big Pharma Outlook webinar recording below and discover how Big Pharma will navigate challenging times for the industry in order to steer towards robust growth.
From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?
13 June 2017
In the developing pharma landscape, it's important to consider all variables to create a winning portfolio strategy. Pharmaceutical companies are attempting to maximize value from all angles, including internal investment in R&D and externalization via deal-making. Learn more about these two models in the webinar recording below.
Datamonitor Healthcare, RxScorecard
Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma
08 June 2017
The multiple myeloma market is evolving, with new therapies and questions about the future of care. Learn about the current assessment payers use for therapies, as well as the significant changes we were seeing in this market during "Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma."
R&D Annual Review Webinar
17 May 2017
In this annual look at the evolution of pharma R&D, we will discuss the industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type, using data from Pharmaprojects.
Winter is coming: Clinical Trial and Site Selection Optimization for Seasonal Respiratory Vaccines
06 December 2016
Get a view of the clinical trial landscape while discovering strategies to optimize site selection within the unique area of developing seasonal respiratory vaccines, including Respiratory Syncytial Virus (RSV) and influenza.
Medtech Insight, Meddevicetracker, In Vivo
21 September 2016
Listen to Amanda Maxwell, Regulatory Affairs Editor, David Filmore, Executive Editor, and Ashley Yeo, Principle Analyst as they focus on medtech regulation and the key changes that are likely to impact the industry in the coming months/years.